These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 26957485)

  • 41. Effects of a low-molecular-weight heparin on thrombus regression and recurrent thromboembolism in patients with deep-vein thrombosis.
    Breddin HK; Hach-Wunderle V; Nakov R; Kakkar VV;
    N Engl J Med; 2001 Mar; 344(9):626-31. PubMed ID: 11228276
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Letters on management of ischemic stroke.
    Porat G
    Am Fam Physician; 2012 Sep; 86(6):492. PubMed ID: 23062038
    [No Abstract]   [Full Text] [Related]  

  • 43. Prevention and treatment of venous thromboembolism.
    Pineo GF; Hull RD
    Drugs; 1996 Jul; 52(1):71-92. PubMed ID: 8799686
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The HAS-BLED score predicts bleedings during bridging of chronic oral anticoagulation. Results from the national multicentre BNK Online bRiDging REgistRy (BORDER).
    Omran H; Bauersachs R; Rübenacker S; Goss F; Hammerstingl C
    Thromb Haemost; 2012 Jul; 108(1):65-73. PubMed ID: 22534746
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Standardized low-molecular-weight heparin bridging regimen in outpatients on oral anticoagulants undergoing invasive procedure or surgery: an inception cohort management study.
    Pengo V; Cucchini U; Denas G; Erba N; Guazzaloca G; La Rosa L; De Micheli V; Testa S; Frontoni R; Prisco D; Nante G; Iliceto S;
    Circulation; 2009 Jun; 119(22):2920-7. PubMed ID: 19470892
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy and safety of peri-procedural bridging therapy with low molecular weight heparin in atrial fibrillation patients under vitamin K antagonists.
    Ríos SJ; Rivera-Caravaca JM; Aroca-Valverde C; Reguilón-Gallego L; Castillo-Rodríguez M; Esteve-Pastor MA; Vicente V; Marín F; Roldán V
    QJM; 2019 Mar; 112(3):183-188. PubMed ID: 30380132
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hemorrhagic complications of anticoagulant treatment: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
    Levine MN; Raskob G; Beyth RJ; Kearon C; Schulman S
    Chest; 2004 Sep; 126(3 Suppl):287S-310S. PubMed ID: 15383476
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Not Available].
    Graf L; Korte W
    Ther Umsch; 2016; 73(10):545-549. PubMed ID: 28045364
    [No Abstract]   [Full Text] [Related]  

  • 50. [Low-molecular-weight heparin in deep venous thrombosis. Dosage for all weight classes].
    MMW Fortschr Med; 2003 Jun; 145(24):56. PubMed ID: 12866309
    [No Abstract]   [Full Text] [Related]  

  • 51. Therapeutic endoscopy-related GI bleeding and thromboembolic events in patients using warfarin or direct oral anticoagulants: results from a large nationwide database analysis.
    Nagata N; Yasunaga H; Matsui H; Fushimi K; Watanabe K; Akiyama J; Uemura N; Niikura R
    Gut; 2018 Oct; 67(10):1805-1812. PubMed ID: 28874418
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 'Heparin rebound' means the opposite in cardiac surgery (bleeding) and in cardiology (thrombosis).
    Koracevic G
    Blood Coagul Fibrinolysis; 2010 Mar; 21(2):198-9. PubMed ID: 20118712
    [No Abstract]   [Full Text] [Related]  

  • 53. Safety and Efficacy of Bridging With Low-Molecular-Weight Heparin During Temporary Interruptions of Warfarin: A Register-Based Cohort Study.
    Sjögren V; Grzymala-Lubanski B; Renlund H; Svensson PJ; Själander A
    Clin Appl Thromb Hemost; 2017 Nov; 23(8):961-966. PubMed ID: 28468510
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tonsillectomy in the anticoagulated patient.
    Cole SM; Patterson MB; Cupp CL
    Ann Otol Rhinol Laryngol; 2007 Aug; 116(8):589-93. PubMed ID: 17847726
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Practice of bridging anticoagulation: guideline adherence and risk factors for bleeding.
    Eijgenraam P; ten Cate H; ten Cate-Hoek AJ
    Neth J Med; 2014 Apr; 72(3):157-64. PubMed ID: 24846933
    [TBL] [Abstract][Full Text] [Related]  

  • 56. LMWH for perioperative anticoagulation in patients on chronic warfarin therapy.
    Heuts LM; Arvik BM; Cender DE
    Ann Pharmacother; 2004 Jun; 38(6):1065-9. PubMed ID: 15113980
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of six-month outcome of patients initially treated for acute deep vein thrombosis with a low molecular weight heparin Certoparin at a fixed, body-weight-independent dosage or unfractionated heparin.
    Harenberg J; Riess H; Büller HR; Brom J; Weidinger G; Huisman MV
    Haematologica; 2003 Oct; 88(10):1157-62. PubMed ID: 14555312
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Perioperative anticoagulant management.
    Grant PJ; Brotman DJ; Jaffer AK
    Med Clin North Am; 2009 Sep; 93(5):1105-21. PubMed ID: 19665623
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Short-Term Risk of Bleeding During Heparin Bridging at Initiation of Vitamin K Antagonist Therapy in More Than 90 000 Patients With Nonvalvular Atrial Fibrillation Managed in Outpatient Care.
    Bouillon K; Bertrand M; Boudali L; Ducimetière P; Dray-Spira R; Zureik M
    J Am Heart Assoc; 2016 Oct; 5(11):. PubMed ID: 27799233
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Update in bridging anticoagulation.
    Kaatz S; Paje D
    J Thromb Thrombolysis; 2011 Apr; 31(3):259-64. PubMed ID: 21327504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.